Euro zone inflation at a 3-year high forces ECB toward a hike — buy European banks that profit from higher rates

Verdict: real margin story, unconfirmed setup — wait for the trigger

The hiking-cycle thesis has genuine fundamental footing as of 4 November 2026: euro-zone inflation hit 4% with an ECB hike flagged as imminent (per CNBC and Reuters), and ING's fiscal 2025 revenue rose 21.8% to €25.7B with net income up 56.1% to €8.3B — the mechanism working in real time. But the trading evidence is nearly nonexistent: the only completed backtest is a single BCS trade over one month (about +0.2%), and all longer windows could not be measured because ING's raw and adjusted price histories sit on different bases. The strongest point against is that the basket is two-thirds one bet — BCS and EUFN correlate at 0.81 — and ING, the offset leg, is also the weakest momentum name, trading 17.1% below its range high with RSI at 23.6. None of the three names meets its entry rules today; BCS is closest, 0.4 RSI points and roughly 0.9% of price away from confirmation. We rate this a wait over the next three months: thesis confidence is medium-high, trade readiness is not there yet, and an ECB pivot to cuts would undercut the entire margin story.

Trade now: wait for the BCS reclaim to confirm before acting

Wait. The business thesis — European banks earning wider lending margins in a hiking cycle — is interesting and supported by fundamentals: Barclays' fiscal 2025 net income rose 13.7% to £7.17B and ING's rose 56.1% to €8.32B with return on equity up to 15.4%. But attractive thesis is not met entry conditions. As of the November 4, 2026 market read, none of the three listed names satisfies all of its entry rules. BCS is closest: its 44.6 RSI (a 0–100 momentum gauge) is 0.4 points below the required 45, and its $22.40 close is about 0.9% below the Bollinger middle band at $22.61 it needs to reclaim. EUFN and ING are further away (RSI 40.8 and 23.6 respectively). "Waiting" here means concrete, observable conditions: a daily close for BCS above $22.61 with RSI at or above 45, while trend strength (ADX above 18, already met at 30.6) stays intact. The trading horizon is swing-length, per the strategy's 60-day maximum holding rule. The downside that matters: these are volatile bank stocks — BCS drew down 27.1% over the past two years of data — and the frozen strategy carries a hard 2% loss stop plus a stop below the second support level once a position is live. On evidence: the supplied backtest covers only one completed trade over one month (BCS, about +0.2% return, win rate on a single trade is not statistically meaningful), and longer windows could not be measured because ING's raw and adjusted price histories sit on different bases. So this is not a multi-year validated system — treat the entry rules as the plan, not as proof the trade works. No parameter optimization was completed for the same reason, so no robust alternative setup was established. ### Technical details Entry rules (all daily bars, observed Nov 4, 2026, 13:08 UTC): - **BCS ($22.40)**: (1) close crosses above Bollinger middle band (20-day, 2 std dev) — not met, $0.21 below the $22.61 trigger (~0.9% away); (2) RSI (14) above 45 — not met, at 44.6; (3) ADX (14) above 18 — met at 30.6. ADX above 25 generally indicates a established trend. An alternate Fibonacci-retracement entry (low touches the 61.8% level, close back above it, RSI above 45) is also pending — the RSI leg is the blocker. - **EUFN ($37.87)**: price $0.43 below its $38.3 band trigger (~1.1% away); RSI 40.8 vs 45 required; ADX met at 30.6. - **ING ($30.90)**: far from triggers — $2.10 (~6.4%) below its $33 band; RSI 23.6, deeply oversold territory; ADX met at 31.6. Exits once in: take profit near first resistance (BCS $23.00, EUFN $38.34, ING $30.97), RSI above 72, a hard 4% gain target, stop at a 2% loss or a close below the second support level, and a 60-bar time exit. Position sizing: fixed 2% risk per name, max 33.3% each. Reward:risk per the fixed rules is 2:1 (4% target vs 2% stop) before the structural levels are reached.

Hiking-cycle tailwind meets record earnings at Barclays and ING

The macro trigger is fresh and the two covered banks just posted their strongest fundamentals in years, giving the bullish hiking-cycle thesis genuine fundamental footing. Note upfront on the strategy evidence: this is a backtested setup, but the completed measurement covers only the most recent one-month window, with a single trade on BCS returning about 0.23% and zero drawdown — one trade is directional evidence, not statistical proof. ### The macro catalyst is current, not speculative Euro zone inflation hit 4% for the first time in three years, with an ECB rate hike flagged as imminent (per CNBC and Reuters, both dated 4 November 2026), and Australia's central bank lifted rates to an 18-year high with a split vote pointing to further tightening (per Reuters, 3 November 2026). The idea argues that hikes widen net lending margins for European banks. That mechanism applies most directly to retail-and-commercial lenders like ING, whose margins are driven by deposit-and-loan spreads. ### ING delivers the thesis numbers today ING's fiscal 2025 results (year ended 31 December 2025) show revenue up 21.8% year over year to €25.7B, net income up 56.1% to €8.3B, net margin up 7.1 points to 32.4%, and return on equity up 5.3 points to 15.4% — placing ING in the 82nd percentile of 920 Financials peers on ROE and the 69th percentile of 774 on revenue growth. Rising rates flowing through to wider margins is exactly the causal chain the idea describes, and ING is already realizing it. ### Barclays adds a shrinking-share-count compounding story Barclays' fiscal 2025 net income rose 13.7% to £7.2B and net margin reached 64.6% (up 5.7 points), while shares outstanding fell 3.8% year over year to about 13.9B — the continuation of a buyback trend from roughly 17.4B shares in 2020. Operating cash flow jumped 163% to £18.7B. Falling share count means each pound of profit supports more value per share, a second, independent driver alongside rate-driven margin expansion. ### Dividends confirm capital-generation capacity Both banks are returning growing amounts of cash: Barclays' 2026 annual dividend total of $0.62 per share is up 42.9% from 2025's $0.434, and ING's 2026 total of $1.338 is up 38.4% from $0.967. Dividends of that growth rate are hard to sustain unless earnings and capital generation are genuinely improving — which they are, per the fundamentals above. ### Institutional ownership is quietly building Provisional 13F data for the quarter ended 30 September 2026 shows 86 institutional holders reporting ING positions (about 6.6M shares) and 54 holders for BCS (about 5.5M shares). The coverage is provisional and single-reporter, so treat it as a soft confirmation signal rather than strong evidence, but it does not contradict the accumulation narrative.

One trade, one month, and a cash-flow red flag: where the thesis is thin

The fundamentals partly support the rate-margin thesis, but the trading evidence is nearly nonexistent, one beneficiary's cash conversion is questionable, and the ETF leg of the idea has no fundamental coverage at all. ### The backtest is one trade in one…

Scores

• Conviction score breakdown: 47
• Thesis support: 70
• Trade readiness: 35
• Risk quality: 45
• Backtest evidence: 15
• Fundamentals trend: 72

Watch items

• BCS — Daily close vs Bollinger middle band (20)
• BCS — RSI (14)
• EUFN — RSI (14)
• ING — RSI (14)
• BCS — Price vs first resistance